⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL578817 | 0.77 | — | — | |
| SCHEMBL3908778 | 0.75 | — | — | |
| SCHEMBL578669 | 0.74 | — | — | |
| SCHEMBL3365726 | 0.72 | CES2 (0.52) | — | |
| SCHEMBL16240425 | 0.72 | CES2 (0.52) | — | |
| SCHEMBL962303 | 0.72 | — | — | |
| SCHEMBL18955393 | 0.72 | CES2 (0.52) | — | |
| SCHEMBL18955326 | 0.72 | CES2 (0.52) | — | |
| SCHEMBL12004277 | 0.72 | — | — | |
| SCHEMBL11856981 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112689509-B | Heterocyclic sulfonamide derivatives and pharmaceutical uses thereof | 梅特恩生物科学有限公司 | 2024-03-29 | — | — | CN | claimed |
| US-20230374014-A1 | CGAS INHIBITING TRIAZOLOPYRIMIDONE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2023-11-23 | — | — | US | claimed |
| EP-3849663-B1 | PYRIMIDINYL-HETEROARYLOXY-NAPHTHYL COMPOUNDS AND METHODS OF USE | GENENTECH INC (US) | 2023-08-02 | — | — | EP | claimed |
| CN-115974713-A | Fluorine-containing compound, preparation method and compound containing fluorine-containing compound | 中国科学技术大学 | 2023-04-18 | — | — | CN | claimed |
| EP-4153593-A1 | CGAS INHIBITING TRIAZOLOPYRIMIDONE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2023-03-29 | — | — | EP | claimed |
| US-20230089582-A1 | 1,2,4-TRIAZINE-3,5-DIONE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | KPC PHARMACEUTICALS INC (CN) | 2023-03-23 | — | — | US | claimed |
| EP-3566863-B1 | PHOTONIC CRYSTAL STRUCTURE AND ANTI-FORGERY COLOR CONVERSION FILM COMPRISING SAME | KOREA RES INST CHEMICAL TECH (KR) | 2023-03-08 | — | — | EP | claimed |
| CN-115667265-A | CGAS-inhibiting triazolopyrimidinone derivatives | 豪夫迈·罗氏有限公司 | 2023-01-31 | — | — | CN | claimed |
| US-11531150-B2 | Photonic crystal structure and anti-forgery color conversion film comprising same | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2022-12-20 | — | — | US | claimed |
| CN-115073544-A | PARP inhibitor pyrazoloquinine derivative and synthesis method thereof | 上海应用技术大学 | 2022-09-20 | — | — | CN | claimed |
| WO-1992007834-A1 | N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1992-05-14 | — | — | WO | claimed |
| WO-1992005161-A1 | 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1992-04-02 | — | — | WO | claimed |
| WO-1992004335-A2 | RENAL-SELECTIVE BIPHENYLALKYL 1H-SUBSTITUTED-1,2,4-TRIAZOLE ANGIOTENSIN II ANTAGONISTS FOR TREATMENT OF HYPERTENSION | G.D. SEARLE & CO. (US) | 1992-03-19 | — | — | WO | claimed |
| WO-1992002257-A2 | RENAL-SELECTIVE ANGIOTENSIN II ANTAGONISTS FOR TREATMENT OF HYPERTENSION | G.D. SEARLE & CO. (US) | 1992-02-20 | — | — | WO | claimed |
| WO-1991018888-A1 | N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1991-12-12 | — | — | WO | claimed |
| WO-1991017148-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1991-11-14 | — | — | WO | claimed |
| EP-0398072-A2 | Amino-acid amides | BAYER AG (DE) | 1990-11-22 | — | — | EP | claimed |
| EP-0148501-B1 | 5-HALOALKYL-1,3,4-THIADIAZOL-2-YLOXYAMIDES | BAYER AG (DE) | 1988-05-11 | — | — | EP | claimed |
| EP-0148501-A1 | 5-Haloalkyl-1,3,4-thiadiazol-2-yloxyamides | BAYER AG (DE) | 1985-07-17 | — | — | EP | claimed |
| US-3988361-A | HYPOTENSIVE AGENTS, ANTILIPOLYTIC AGENTS; PROSTAGLANDIN DERIVATIVES | THE UPJOHN COMPANY (US) | 1976-10-26 | — | — | US | claimed |